nsc-87877 has been researched along with sb 203580 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbieri, E; Chen, Z; Cheng, J; Fan, Y; Jin, J; Kim, ES; Ma, IT; Patel, RH; Rojas, Y; Shang, X; Shi, Y; Shohet, JM; Vasudevan, SA; Yang, J; Yu, Y; Zhao, Y | 1 |
1 other study(ies) available for nsc-87877 and sb 203580
Article | Year |
---|---|
NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Dual-Specificity Phosphatases; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Kidney; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Phosphatases; Molecular Chaperones; Neuroblastoma; p38 Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Pyridines; Quinolines; RNA, Small Interfering; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |